Likewise, GLP-1(9-36)amide could reverse AD-related alterations in hippocampal synaptic plasticity and memory deficits, but did not alter levels of APP and Aβ in APP/PS1 mice (218). The gene discussed is GCG; the disease is Alzheimer disease.